|
1
|
Ohgaki H: Epidemiology of brain tumors.
Methods Mol Biol. 472:323–342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegal T: Clinical impact of molecular
biomarkers in gliomas. J Clin Neurosci. 22:437–444. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Helseth R, Helseth E, Johannesen TB,
Langberg CW, Lote K, Rønning P, Scheie D, Vik A and Meling TR:
Overall survival, prognostic factors, and repeated surgery in a
consecutive series of 516 patients with glioblastoma multiforme.
Acta Neurol Scand. 122:159–167. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lefranc F, Brotchi J and Kiss R: Possible
future issues in the treatment of glioblastomas: Special emphasis
on cell migration and the resistance of migrating glioblastoma
cells to apoptosis. J Clin Oncol. 23:2411–2422. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Onishi M, Ichikawa T, Kurozumi K and Date
I: Angiogenesis and invasion in glioma. Brain Tumor Pathol.
28:13–24. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, function and role in cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Imbar T and Eisenberg I: Regulatory role
of microRNAs in ovarian function. Fertil Steril. 101:1524–1530.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dogini DB, Pascoal VD, Avansini SH, Vieira
AS, Pereira TC and Lopes-Cendes I: The new world of RNAs. Genet Mol
Biol. 37 1 Suppl:S285–S293. 2014. View Article : Google Scholar
|
|
10
|
Zhu Y, Zhao H, Rao M and Xu S:
MicroRNA-365 inhibits proliferation, migration and invasion of
glioma by targeting PIK3R3. Oncol Rep. 37:2185–2192. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Guan DH, Bi RX, Xie J, Yang CH
and Jiang YH: Prognostic value of microRNAs in gastric cancer: A
meta-analysis. Oncotarget. 8:55489–55510. 2017.PubMed/NCBI
|
|
12
|
Fan N, Zhang J, Cheng C, Zhang X, Feng J
and Kong R: MicroRNA-384 represses the growth and invasion of
non-small-cell lung cancer by targeting astrocyte elevated
gene-1/Wnt signaling. Biomed Pharmacother. 95:1331–1337. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wen F, Xu JZ and Wang XR: Increased
expression of miR-15b is associated with clinicopathological
features and poor prognosis in cervical carcinoma. Arch Gynecol
Obstet. 295:743–749. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ganji SM, Saidijam M, Amini R,
Mousavi-Bahar SH, Shabab N, Seyedabadi S and Mahdavinezhad A:
Evaluation of MicroRNA-99a and MicroRNA-205 expression levels in
bladder cancer. Int J Mol Cell Med. 6:87–95. 2017.PubMed/NCBI
|
|
15
|
Yang T, Thakur A, Chen T, Yang L, Lei G,
Liang Y, Zhang S, Ren H and Chen M: MicroRNA-15a induces cell
apoptosis and inhibits metastasis by targeting BCL2L2 in non-small
cell lung cancer. Tumour Biol. 36:4357–4365. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu G, Liu J, Wu Z, Wu X and Yao X:
MicroRNA-184 inhibits cell proliferation and metastasis in human
colorectal cancer by directly targeting IGF-1R. Oncol Lett.
14:3215–3222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu M, Qin S, Cao F, Ding S and Li M:
MicroRNA-379 inhibits metastasis and epithelial-mesenchymal
transition via targeting FAK/AKT signaling in gastric cancer. Int J
Oncol. 51:867–876. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen JS, Li HS, Huang JQ, Dong SH, Huang
ZJ, Yi W, Zhan GF, Feng JT, Sun JC and Huang XH: MicroRNA-379-5p
inhibits tumor invasion and metastasis by targeting FAK/AKT
signaling in hepatocellular carcinoma. Cancer Lett. 375:73–83.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang J, Fan B, Zhao Y and Fang J:
MicroRNA-202 inhibits cell proliferation, migration and invasion of
glioma by directly targeting metadherin. Oncol Rep. 38:1670–1678.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tong L, Chu M, Yan B, Zhao W, Liu S, Wei
W, Lou H, Zhang S, Ma S, Xu J and Wei L: MTDH promotes glioma
invasion through regulating miR-130b-ceRNAs. Oncotarget.
8:17738–17749. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park SY, Choi M, Park D, Jeong M, Ahn KS,
Lee J, Fisher PB, Yun M and Lee SG: AEG-1 promotes mesenchymal
transition through the activation of Rho GTPases in human
glioblastoma cells. Oncol Rep. 36:2641–2646. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li WF, Dai H, Ou Q, Zuo GQ and Liu CA:
Overexpression of microRNA-30a-5p inhibits liver cancer cell
proliferation and induces apoptosis by targeting MTDH/PTEN/AKT
pathway. Tumour Biol. 37:5885–5895. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu C, Kong X, Wang H, Zhang N, Kong X,
Ding X, Li X and Yang Q: MTDH mediates estrogen-independent growth
and tamoxifen resistance by down-regulating PTEN in MCF-7 breast
cancer cells. Cell Physiol Biochem. 33:1557–1567. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhi T, Jiang K, Zhang C, Xu X, Wu W, Nie
E, Yu T, Zhou X, Bao Z, Jin X, et al: MicroRNA-1301 inhibits
proliferation of human glioma cells by directly targeting N-Ras. Am
J Cancer Res. 7:982–998. 2017.PubMed/NCBI
|
|
26
|
Jiang K, Zhi T, Xu W, Xu X, Wu W, Yu T,
Nie E, Zhou X, Bao Z, Jin X, et al: MicroRNA-1468-5p inhibits
glioma cell proliferation and induces cell cycle arrest by
targeting RRM1. Am J Cancer Res. 7:784–800. 2017.PubMed/NCBI
|
|
27
|
Li P, Wang X, Shan Q, Wu Y and Wang Z:
MicroRNA-130b promotes cell migration and invasion by inhibiting
peroxisome proliferator-activated receptor-γ in human glioma. Oncol
Lett. 13:2615–2622. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khan S, Brougham CL, Ryan J, Sahrudin A,
O'Neill G, Wall D, Curran C, Newell J, Kerin MJ and Dwyer RM:
miR-379 regulates cyclin B1 expression and is decreased in breast
cancer. PLoS One. 8:e687532013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu D, Niu X, Tao J, Li P, Lu Q, Xu A, Chen
W and Wang Z: MicroRNA-379-5p plays a tumor-suppressive role in
human bladder cancer growth and metastasis by directly targeting
MDM2. Oncol Rep. 37:3502–3508. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Z, Shen J, Chan MT and Wu WK:
MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1.
J Cell Mol Med. 21:315–323. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hao GJ, Hao HJ, Ding YH, Wen H, Li XF,
Wang QR and Zhang BB: Suppression of EIF4G2 by miR-379 potentiates
the cisplatin chemosensitivity in nonsmall cell lung cancer cells.
FEBS Lett. 591:636–645. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kaur K, Kakkar A, Kumar A, Purkait S,
Mallick S, Suri V, Sharma MC, Julka PK, Gupta D, Suri A and Sarkar
C: Clinicopathological characteristics, molecular subgrouping, and
expression of miR-379/miR-656 cluster (C14MC) in adult
medulloblastomas. J Neurooncol. 130:423–430. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yamamoto K, Seike M, Takeuchi S, Soeno C,
Miyanaga A, Noro R, Minegishi Y, Kubota K and Gemma A: MiR-379/411
cluster regulates IL-18 and contributes to drug resistance in
malignant pleural mesothelioma. Oncol Rep. 32:2365–2372. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Poon TC, Wong N, Lai PB, Rattray M,
Johnson PJ and Sung JJ: A tumor progression model for
hepatocellular carcinoma: Bioinformatic analysis of genomic data.
Gastroenterology. 131:1262–1270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Song H, Li C, Li R and Geng J: Prognostic
significance of AEG-1 expression in colorectal carcinoma. Int J
Colorectal Dis. 25:1201–1209. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dong L, Qin S, Li Y, Zhao L, Dong S, Wang
Y, Zhang C and Han S: High expression of astrocyte elevated gene-1
is associated with clinical staging, metastasis, and unfavorable
prognosis in gastric carcinoma. Tumour Biol. 36:2169–2178. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nikpour M, Emadi-Baygi M, Fischer U,
Niegisch G, Schulz WA and Nikpour P: MTDH/AEG-1 contributes to
central features of the neoplastic phenotype in bladder cancer.
Urol Oncol. 32:670–677. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Klijn JG, Zhang Y, Sieuwerts AM,
Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu
J, et al: Gene-expression profiles to predict distant metastasis of
lymph-node-negative primary breast cancer. Lancet. 365:671–679.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He Z, He M, Wang C, Xu B, Tong L, He J,
Sun B, Wei L and Chu M: Prognostic significance of astrocyte
elevated gene-1 in human astrocytomas. Int J Clin Exp Pathol.
7:5038–5044. 2014.PubMed/NCBI
|
|
40
|
Xia Z, Zhang N, Jin H, Yu Z, Xu G and
Huang Z: Clinical significance of astrocyte elevated gene-1
expression in human oligodendrogliomas. Clin Neurol Neurosurg.
112:413–419. 2010. View Article : Google Scholar : PubMed/NCBI
|
